The TCGA ESCA patients were separated by their subtypes, and as can be seen in Fig. 3C, both ESCC and EAC patients with higher NAA10 expression levels had a shorter survival time. The gene discussed is NAA10; the disease is esophageal squamous cell carcinoma.